HR 1730 · 116th Congress 2019–2021, ended

Cancer Drug Parity Act of 2019

Latest action · Mar 14, 2019 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 13, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Cancer Drug Parity Act of 2019

This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration.

To comply with this requirement, health plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.

Cosponsors 170

Members who signed on, in the order they did. Signatures ran from Mar 13, 2019 to Dec 18, 2020; 17 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-FLAlcee L. HastingsOriginalMar 13, 2019
D-CAAmi BeraOriginalMar 13, 2019
R-KYBrett GuthrieOriginalMar 13, 2019
R-PABrian K. FitzpatrickOriginalMar 13, 2019
D-FLDebbie Wasserman SchultzOriginalMar 13, 2019
D-WADerek KilmerOriginalMar 13, 2019
D-CADoris O. MatsuiOriginalMar 13, 2019
D-DCEleanor Holmes NortonOriginalMar 13, 2019
R-FLGus M. BilirakisOriginalMar 13, 2019
D-NYJerrold NadlerOriginalMar 13, 2019
R-TXMichael T. McCaulOriginalMar 13, 2019
R-TXPete OlsonOriginalMar 13, 2019
D-ORPeter A. DeFazioOriginalMar 13, 2019
R-NYPeter T. KingOriginalMar 13, 2019
D-CARo KhannaOriginalMar 13, 2019

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 13, 2019
Health Subcommittee
Referred Mar 14, 2019

Actions 3

Everything that happened, newest first.

  1. Mar 14, 2019Referred to the Subcommittee on Health.
  2. Mar 13, 2019Introduced in House
  3. Mar 13, 2019Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 45, March 13, 2019, page H2718.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 741Cancer Drug Parity Act of 2019Identical billMar 12, 2019

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for cost sharing for oral anticancer drugs on terms no less favorable than the cost sharing provided for anticancer medications administered by a health care provider.
Short Title(s) as Introduced
Cancer Drug Parity Act of 2019

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 13, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.